| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/14/2009 | CN101342171A Instant gel rubber of clonidine hydrochloric for eyes |
| 01/14/2009 | CN101342165A Instant gel rubber of thyroxine liothyronine for eyes |
| 01/14/2009 | CN101342163A Instant gel rubber of levobunolol hcl for eyes |
| 01/14/2009 | CN100451103C Method for preparing ophthalmic solution for preventing senile macular degeneration by using microoganism culture |
| 01/14/2009 | CN100451018C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/14/2009 | CN100450518C Ready prepared Chinese medicine for treating epicophosis and sonitus |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | CA2470466C Combinations of viscoelastics for use during surgery |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2397785C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2301032C A method of preventing or treating estrogen-dependent diseases and disorders |
| 01/08/2009 | WO2009006460A1 Rnai-mediated inhibition of htra1 for treatment of macular degeneration |
| 01/08/2009 | WO2009006370A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004990A1 Fp receptor agonist |
| 01/08/2009 | WO2009004792A1 Sulfonamide compound, and crystal thereof |
| 01/08/2009 | WO2009004146A2 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 01/08/2009 | WO2009004114A1 A method of treating amblyopia |
| 01/08/2009 | WO2009004071A1 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 01/08/2009 | WO2007131012A9 12-aryl or heteroaryl prostaglandin analogs |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012145 Therapeutic esters |
| 01/08/2009 | US20090012123 Protective Agent for Retinal Neuronal Cell Comprising Indazole Derivative as Active Ingredient |
| 01/08/2009 | US20090012112 Alpha 1A-adrenoceptor antagonists |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012085 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 01/08/2009 | US20090012058 Prophylactic or Therapeutic Agents For Allergic Ophthalmic Diseases or Allergic Nasal Diseases, Comprising Tricyclic Triazolobenzazepine Derivative |
| 01/08/2009 | US20090012030 RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION |
| 01/08/2009 | US20090011040 Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010911 Methods and compositions for affecting cyclophilin a regulation of kinases in modulating cellular activities |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | CA2692572A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 01/08/2009 | CA2692448A1 A method of treating amblyopia |
| 01/08/2009 | CA2691575A1 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 01/08/2009 | CA2690753A1 Sulfonamide compound and crystal thereof |
| 01/08/2009 | CA2681813A1 Transcription factor modulating compounds and methods of use thereof |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2011495A1 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 01/07/2009 | EP2010561A1 Antimicrobial peptides |
| 01/07/2009 | EP1759702B1 Method of preparing a latanoprost ophthalmic solution and solution thus produced |
| 01/07/2009 | EP1575597B1 Use of rimexolone in the treatment of dry eye |
| 01/07/2009 | EP1478389B1 Treatment for diseases of the eye |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | CN101337987A Anti-cataract target protein |
| 01/07/2009 | CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337932A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337931A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337071A Composition for preparing anti-cataract products |
| 01/07/2009 | CN101337066A Glutathion instant gel for eye |
| 01/07/2009 | CN101337005A Cataract eliminating eyesight recovery pill |
| 01/07/2009 | CN101336994A Houttuynia instant gel for eye |
| 01/07/2009 | CN101336944A Xiaoxingzhang eye instant gel |
| 01/07/2009 | CN101336934A Bear bile buccal tablet and preparation process thereof |
| 01/07/2009 | CN101336923A Eye in-situ gel of pirenoxine sodium |
| 01/07/2009 | CN101336919A Phacolysin eye in-situ gel |
| 01/07/2009 | CN101336912A Eye in-situ gel of compound taurine |
| 01/07/2009 | CN101336887A Drug delivery system using subconjunctival depot |
| 01/07/2009 | CN101336720A Nutrient powder capable of enhancing eyesight |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/07/2009 | CN100448447C Preparation of superfine prednisolone powder |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473704 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
| 01/06/2009 | US7473679 Treatments employing neuronal exocytosis-inhibiting peptides |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/01/2009 | US20090005459 NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau |
| 01/01/2009 | US20090005450 Use of creatine compounds for the treatment of eye disorders |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005362 Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005317 Methods for treating a corneal disorder and promoting skin wound healing |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004207 Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001857A1 Composition for ophthalmic disease associated with hypoxia or ischemia |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001396A1 Disposable sterile ocular solution for corneal cross- linking of cheratocone, and process for production thereof |
| 12/31/2008 | WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | WO2009000296A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 12/31/2008 | WO2008132568A3 Fusion proteins binding to growth factors |
| 12/31/2008 | EP2008658A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
| 12/31/2008 | EP2007408A2 Preventative treatment and remission of allergic diseases |
| 12/31/2008 | EP2007354A1 Brimonidine and timolol compositions |
| 12/31/2008 | EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 12/31/2008 | EP1309587B1 Cinnoline compounds |
| 12/31/2008 | EP0968716B1 Drugs for ameliorating ocular circulatory disorders |
| 12/31/2008 | CN101336113A Pharmaceutical comprising PPAR agonist |